Successful removal of a perforating ventricular lead after idarucizumab administration

Kardiol Pol. 2020 Apr 24;78(4):350-351. doi: 10.33963/KP.15177. Epub 2020 Feb 5.

Authors

Sylwia Sławek-Szmyt¹, Aleksander Araszkiewicz², Lidia Chmielewska-Michalak², Zofia Oko-Sarnowska², Maciej Lesiak², Przemysław Mitkowski²

Affiliations

¹ 1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland. sylwia.slawek@skpp.edu.pl
² 1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland

PMID: 32024809
DOI: 10.33963/KP.15177

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized*
Antithrombins
Dabigatran*
Humans

Substances

Antibodies, Monoclonal, Humanized
Antithrombins
idarucizumab
Dabigatran